India Still Viable for Drug Innovation, Hisey Says

April 1 (Bloomberg) -- Terry Hisey, vice chairman and U.S. life sciences leader at Deloitte LLP, talks about a ruling by India's Supreme Court denying Novartis AG's request for patent protection for its Gleevec cancer treatment. He speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Goldman’s Daly Says EU Likely to Remain Resilient
37:58 - Kevin Daly, senior European economist at Goldman Sachs, discusses parallels in economic data between Japan and Europe, and monetary policy from various central banks. He speaks with Jonathan Ferro on Bloomberg Television’s “On The Move.” (Source: Bloomberg)
  • Is Tesco Cannibalizing Itself?
  • House Building Tops Conservative Party Conference
  • Is the Doom and Gloom in Emerging Markets Overdone?